The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
Open accessAbstract
Background & aims Several case series have reported the effects of fecal microbiota transplantation (FMT) for ulcerative colitis (UC). We assessed the efficacy and safety of FMT for patients with UC in a double-blind randomized trial.Methods Patients with mild to moderately active UC (n = 50) were assigned to groups that underwent FMT with feces from healthy donors or were given autologous fecal microbiota (control); each transplant was administered via nasoduodenal tube at the start of the study and 3 weeks later. The study was performed at the Academic Medical Center in Amsterdam from June 2011 through May 2014. The composite primary end point was clinical remission (simple clinical colitis activity index scores ≤2) combined with ≥1-point decrease in the Mayo endoscopic score at week 12. Secondary end points were safety and microbiota composition by phylogenetic microarray in fecal samples.Results Thirty-seven patients completed the primary end point assessment. In the intention-to-treat analysis, 7 of 23 patients who received fecal transplants from healthy donors (30.4%) and 5 of 25 controls (20.0%) achieved the primary end point (P = .51). In the per-protocol analysis, 7 of 17 patients who received fecal transplants from healthy donors (41.2%) and 5 of 20 controls (25.0%) achieved the primary end point (P = .29). Serious adverse events occurred in 4 patients (2 in the FMT group), but these were not considered to be related to the FMT. At 12 weeks, the microbiota of responders in the FMT group was similar to that of their healthy donors; remission was associated with proportions of Clostridium clusters IV and XIVa.Conclusions In this phase 2 trial, there was no statistically significant difference in clinical and endoscopic remission between patients with UC who received fecal transplants from healthy donors and those who received their own fecal microbiota, which may be due to limited numbers. However, the microbiota of responders had distinct features from that of nonresponders, warranting further study. ClinicalTrials.gov Number: NCT01650038.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, in two randomized controlled trials of UC patients, FMT responders showed a higher similarity to their donors than nonresponders. 61,62”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [61]
In the citing paper
“One trial, in which two faecal transplants were given via the upper GI route, showed no difference in clinical or endoscopic remission between the faecal transplant group and the control group (given autologous stool).76”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [76]
In the citing paper
“Since that meta-analysis, two randomised controlled trials in UC show discrepant results.”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [76]
In the citing paper
“Remission (full Mayo score <3 and complete mucosal healing) was achieved in 24% of patients after FMT and 5% with placebo; stool from patients receiving FMT had greater microbial diversity than that of patients given placebo.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [77]
In the citing paper
“In the study by Moayyedi et. al, seventy-five patients with active UC were randomized to a weekly FMT or water enema for 6 weeks, and there was a statistically significant difference in remission, the primary outcome, between the two groups.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [77]
In the citing paper
“However, some researchers did not find significant differences in the efficacy of FMT, which may be related to the number and cycle of enemas, preparation process, and limited numbers (147, 148).”
From Stress triggers flare of inflammatory bowel disease in children and adults (2019) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P. J., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A. D., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,910
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Self-citationCoated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,037
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Self-citationVedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P. J., Sands, B. E., Hanauer, S. B., Colombel, J., Sandborn, W. J., Assche, G. V., Axler, J. L., Kim, H. J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,892
Classification of Inflammatory Bowel Disease
Lennard‐Jones, J. E. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091339 · Cited by 2,022
Canoco Reference Manual and User’s Guide: Software for Ordination (version 5.0)
ter Braak, C. J. F., & Šmilauer, P. (2012) · Cited by 1,898
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Claesson, M. J., O’Sullivan, Ó., Wang, Q., Nikkilä, J., Marchesi, J. R., Smidt, H., de Vos, W. M., Ross, R. P., & O’Toole, P. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006669 · Cited by 900
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 922
Reveles, K. R., Hickmott, A. J., Strey, K. A., Mustoe, A. C., Arroyo, J. P., Power, M. L., Ridenhour, B. J., Amato, K. R., & Ross, C. N. (2024) · Microorganisms · doi:10.3390/microorganisms12050852 · Cited by 1
Yang, Y., Zhang, Z., Wang, Y., Rao, J.-H., Sun, J., Wu, Z., He, J., Tan, X., Liang, L., Yu, Q., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00388-24 · Cited by 1
Gut microbiota and gastrointestinal tumors: insights from a bibliometric analysis
Chen, C., Wang, X., Han, X., Peng, L., & Zhang, Z. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1558490 · Cited by 1
Das Mikrobiom bei chronischen Erkrankungen
Schüppel, V. L., & Haller, D. (2016) · Der Diabetologe · doi:10.1007/s11428-016-0124-3 · Cited by 1
Gut Flora: In the Treatment of Disease
Bhardwaj, S. B. (2016) · InTech eBooks · doi:10.5772/65073 · Cited by 1
Nanotherapeutics for Inflammatory Bowel Disease
Xiao, B., & Merlin, D. (2017) · Routledge eBooks · doi:10.1201/9781315152356-7 · Cited by 1
Fecal Microbial Transplant- A New Hope of Treatment for Ulcerative Colitis
Butta, H., Kapoor, A., Sibal, A., Sardana, R., Bhatia, V., & Mendiratta, L. (2018) · International Journal of Medicine and Public Health · doi:10.5530/ijmedph.2018.1.2 · Cited by 1
Microbiota, Prebiotics, Antibiotics and Fecal Microbiota Transfer
Nörenberg, J., Vogler, S., & Stallmach, A. (2019) · Springer eBooks · doi:10.1007/978-3-319-75022-4_14 · Cited by 1
Cho, Y. (2019) · Intestinal Research · doi:10.5217/ir.2018.00171 · Cited by 1
Darmmikrobiom und chronisch-entzündliche Darmerkrankungen
Schwerd, T., & Koletzko, S. (2019) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-019-0683-7 · Cited by 1
[Development and prospects of fecal microbiota transplantation].
Hu, Y., & Lü, B. (2019) · PubMed Central · doi:10.3785/j.issn.1008-9292.2019.06.16 · Cited by 1
Microbiologic Approaches to Treating Inflammatory Bowel Disease.
Fischer, M. (2021) · Europe PMC (PubMed Central) · Cited by 1
(2020) · Microbiology Australia · doi:10.1071/mav41n2 · Cited by 1
Wang, X., Wu, J., Huang, R., & Wang, S. (2022) · The Anatomical Record · doi:10.1002/ar.25135 · Cited by 1
Ponsioen, C. Y., Zoetendal, E. G., Rossen, N., Fuentes, S., & de Vos, W. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.11.036 · Cited by 1
Self-citationJackson, B. D. (2019) · Minerva Access (University of Melbourne) · Cited by 1
The Microbiome as a Therapy in Pouchitis and Ulcerative ColitisPreprint
Segal, J. P., LeBlanc, J., Braz, L. M. D. C., & Hart, A. L. (2021) · Preprints.org · doi:10.20944/preprints202103.0022.v1 · Cited by 1
The role of hydrogenotrophic microbiota in the human gut
Wang, T. (2022) · doi:10.18174/569022 · Cited by 1
Chan, C. (2016) · Scholarship - Claremont (Claremont Colleges)
1) Microbiota and Gastrointestinal Disease
Kanai∥, T. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.111a
Eun, C. S. (2017) · Intestinal Research · doi:10.5217/ir.2017.15.2.145
Vancomycin in Very-Early Onset Inflammatory Bowel Disease-Dysbiosis: Fight Fire with Fire?
Biedermann, L. (2017) · Digestion · doi:10.1159/000477088
The Different Drummer: Non-traditional Therapeutic Approaches
Yen, E. F. (2017) · Clinical gastroenterology · doi:10.1007/978-3-319-53763-4_12
Therapeutic Manipulation of Gut Microbiota
Ishiguro, E. E., Haskey, N., & Campbell, K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-810541-2.00007-5
Fecal transplant is superior to oral vancomycin for treatment of recurrent Clostridium difficile
Weber, K. (2018) · Clinical Research in Practice The Journal of Team Hippocrates · doi:10.22237/crp/1536883500
Omics technologies and the choice of treatment strategy for inflammatory intestinal diseases
Угаров, И. В., Смирнова, О. А., Lychkova, A. E., & Kostyuchenko, L. N. (2018) · Russian Journal of Evidence-Based Gastroenterology · doi:10.17116/dokgastro2018703118
Savelkoul, E. H. J., Pathmakanthan, S., Hawkey, P. M., & Iqbal, T. H. (2018) · Gastrointestinal Nursing · doi:10.12968/gasn.2018.16.9.43
Gracie, D. J. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Khanna, R., Levesque, B. G., McDonald, J. W., & Feagan, B. G. (2019) · Wiley eBooks · doi:10.1002/9781119211419.ch10
Kao, D. H., & Surawicz, C. M. (2019) · Encyclopedia of Gastroenterology · doi:10.1016/b978-0-12-801238-3.65954-8
Advances in personalized gastroenterology and hepatology 2016
Hubert, E. B. (2016) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2016-26-3-4-10
(2019) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12241
The Microbiome in Liver Diseases
Blum, H. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-24432-3_19
A Review on Stool Transplantation
Rajani Chowdary, A. (2018) · Journal of Infectious Diseases & Travel Medicine · doi:10.23880/jidtm-16000106
1) Microbiota and Gastrointestinal Disease
Kanai∥, T. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.1695
Jin, C., Hu, Y. C., & Jin, B. (2020) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v28.i4.135
Self-administered Fecal Microbial Transplants—What Could Possibly Go Wrong?
Raffals, L. E. (2020) · Crohn s & Colitis 360 · doi:10.1093/crocol/otaa025
Therapeutic Potential of Gut Microbiome Manipulation: Concepts in Fecal Microbiota Transplantation
Nikhra, V. (2019) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2019.11.555803
Metagenomics in One Health — from standardization to targeted application
Hallmaier–Wacker, L. K. (2020) · doi:10.53846/goediss-7952
The future of faecal microbiota transplantation in gastrointestinal illness
Reed, H., & Begun, J. (2020) · Microbiology Australia · doi:10.1071/ma20027
Abdominal pain: focus on inflammatory bowel diseases
Te, P. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-4-114-124
Shrainer, E. V., Хавкин, А. И., & Vlassov, V. V. (2020) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-179-7-69-77
Die Anwendung von Natural Language Processing zur kompakten Erfassung einer Krankheit
Boichak, O., & Buchkremer, R. (2020) · FOM-Edition · doi:10.1007/978-3-658-29550-9_22
The hardware method of biomaterial preparation for fecal transplantation
Shedoeva, L. R., Chashkova, E. Y., Геннадьевна, К. О., & Kogan, G. Y. (2020) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2020-48-060
Концепция супердонора и другие возможные факторы эффективности трансплантации фекальной микробиоты
Ткач, С. М., Dorofeev, A. E., & Kuzenko, Y. G. (2020) · GASTROENTEROLOGY · doi:10.22141/2308-2097.54.3.2020.211740
La dysbiose intestinale dans les maladies inflammatoires chroniques de l’intestin
Altwegg, R., & Michon, A.-L. (2020) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(20)30357-9
Fecal Microbiota Transplantation in Intestinal Disorders: A Primer for Physicians
Sood, A., Midha, V., Kaur, H., & Singh, A. (2020) · JOURNAL OF GASTROINTESTINAL INFECTIONS · doi:10.5005/jp-journals-10068-3041
Li, Y., Sun, Y., Zhong, S. S., Huo, J., Sun, L., Zhang, F., Zhu, J., & Wu, C. (2020) · Research Square · doi:10.21203/rs.3.rs-119478/v1
Is the New Approach in Inflammatory Bowel Disease Treat-to-Target?
Vinod Kumar, P. (2021) · Internationale Pharmaceutica Sciencia · doi:10.31531/2231-5896.1000111
Current status, complications and prospects of fecal microbiota transplantation therapy
Ohara, T. (2021) · Archives of Pathology and Clinical Research · doi:10.29328/journal.apcr.1001021
Francella, C., & Foster, J. A. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc297
Fan, M., Zhang, Z., Ruan, G., Fang, W., Gu, X., Xi, T., & Xing, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-444129/v1
Microbiota Based Management of the Gastrointestinal Disorders
Mouli, V. P., & Ahuja, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00011-5
Bozza, M. J., Vilar, J. M. M., & Kozusny‐Andreani, D. I. (2020) · Research Society and Development · doi:10.33448/rsd-v9i11.9648
FÖRÄLDER TILL EN ÄNGEL : Upplevelser av välbefinnande och lidande efter att barn avlidit i cancer
Gunnarsson, A. B., & Nylander, L. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
国家の対外行動分析における国内要因--ネオクラシカル・リアリズムアプローチに向けての一考察
水沢, 紀. (2007) · 政治学研究論集
ELECTRON RAY SCANNING SYSTEM FOR MEASUREMENT OF PHOTOGRAPHS FROM BUBBLE CHAMBERS.
Berlin, N. I., Vertlib, I. L., Gorelov, A. A., Кац, Б. М., Markovich, M. G., Ovchinnikov, E. K., Rubchinskii, S. M., Uvarov, V., & Tsukkerman, I. I. (1973) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
Update on fecal microbial transplantation for the treatment of inflammatory bowel disease
Llirós, M., Lluansí, A., Peries, L., Bahí, A., Ramió‐Pujol, S., & Aldeguer, X. (2021) · Journal of IMIDs · doi:10.24875/jimids.m21000008
(2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.62
1) Microbiota and Gastrointestinal Diseases
Kanai∥, T. (2019) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.108.401
Davidovics, Z. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-67293-1.00093-1
Faecal microbiota transplantation for ulcerative colitis
(2017) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2017.5.0474
Xu, H., Chen, Q., Fan, Y., Zhang, B., Yan, C., Zhang, Q., Ke, Y., Chen, Z., Wang, L., Shi, H., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1606914/v1
Possible factors determining efficacy of fecal microbiota transplantation. Review
Ткач, С. М., Kharchenko, N. V., & Dorofeev, A. E. (2022) · Modern Gastroenterology · doi:10.30978/mg-2022-1-48
Garbuzenko, D. V. (2022) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2022-12-5-352-362
Questions to consider when caring for patients with ulcerative colitis
Hasselblatt, P., Reindl, W., Gauss, A., Neeff, H. P., Fusco, S., & Klaus, J. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1890-6015
Fecal microbiota transplantation and ulcerative colitis remission: A meta-analysis
Mirghani, H. O., AlShalawi, A. A., Algabri, M. O., Albalawi, T. S., Albalawi, A. M. F., Albalawi, A. N. S., Alzamhari, O. S. A., Alshahrani, M. M. M., Albalawi, M. A. I., Alquthami, H. H. M., et al. (2022) · Medical Science · doi:10.54905/disssi/v26i130/ms570e2672
Microbiota: ¿Sabemos de qué estamos hablando?
Eriutina, N. A. (2021) · Archivos de coloproctología · doi:10.26754/ojs_arcol/archcolo.202146350
Realising the potential of faecal microbiota transplant
Dowden, A. (2023) · Prescriber · doi:10.1002/psb.2043
Gut microbiota analysis and faecal transplantation to improve surgical outcomes
Cunningham, A., & Harris, D. A. (2023) · British journal of surgery · doi:10.1093/bjs/znad102
Targeting the Gut Microbiota for Health
Ishiguro, E. E., Haskey, N., & Campbell, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91387-4.00005-3
Zukünftige Therapieoptionen für chronisch-entzündliche Darmerkrankungen
Bertram, F., Kempski, J., & Huber, S. (2023) · Die Gastroenterologie · doi:10.1007/s11377-023-00735-x
Does Neonatal Microbiome Research Encompass the Placental Transfer Pathway?
Choi, Y. (2023) · Neonatal Medicine · doi:10.5385/nm.2023.30.4.96
Intestinal Mucosal Immunity Caused Autoimmune Diseases
Nie, X., Zhang, Y., Yang, H., Chen, Y., Zhang, Y., Cai, J.-P., Tang, Y., Fan, Q., Cai, G., Zhao, A.-L., et al. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002960
The gut microbiome in the onset and progression of Inflammatory Bowel Diseases
Klaassen, M. A. Y. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.909058157
Microbiota-related biomarkers for precision medicine and drug discovery
Foster, J. A., & Clarke, G. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-814800-6.00012-1
Shimizu, H., Arai, K., Asahara, T., Takahashi, T., Tsuji, H., Matsumoto, S., Takeuchi, I., Kyodo, R., & Yamashiro, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16779834
Shtossel, O., Turjeman, S. C., Riumin, A., Goldberg, M. R., Elizur, A., Bekor, Y., Mor, H., Koren, O., & Louzoun, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23949883
Bakr, A. A., Sarwar, S., Aslam, M. N., Ghias, M., & Yousuf, M. N. (2024) · Annals of King Edward Medical University · doi:10.21649/akemu.v30i1.5188
Volkmann, E. R., & McMahan, Z. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_32
Fecal microbiota transplantation: a step into the past or the future? A review
Zakharova, I. N., & Gostyukhina, A. D. (2024) · Pediatrics Consilium Medicum · doi:10.26442/26586630.2024.2.202972
Fecal Microbiota Transplantation
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_36
Fecal microbiota transplantation - current trends and future perspectives
Stebel, R. (2025) · Medicína pro praxi · doi:10.36290/med.2025.014
Jakinala, P., Lavudi, H. N., Babu, B. N., Angadala, D. S. L., Revanth, A., Rachel, K. V., Sekhar, C. C., Sabbi, A. V., Ravula, U., & Katika, M. R. (2025) · Advances in Microbiology · doi:10.4236/aim.2025.158028
Glazar, M., & Facchin, S. (2025) · Academia Nutrition and Dietetics · doi:10.20935/acadnutr7951
Yoshinami, Y., Shoji, H., Okita, N. T., & Kato, K. (2025) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2025.21.2.5
Wilson, B. C., Vatanen, T., Jayasinghe, T. N., Leong, K. S. W., Derraik, J. G., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14594448
Wilson, B. C., Vatanen, T., Jayasinghe, T. N., Leong, K. S. W., Derraik, J. G., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14594445
Wilson, B. C., Vatanen, T., Jayasinghe, T. N., Leong, K. S. W., Derraik, J. G., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14594451
Crothers, J. W., Chu, N. D., Nguyen, L. T. T., Phillips, M., Collins, C. C., Fortner, K. A., del Río, R., Lavoie, B., Callas, P., Velez, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14936581
Crothers, J. W., Chu, N. D., Nguyen, L. T. T., Phillips, M., Collins, C. C., Fortner, K. A., del Río, R., Lavoie, B., Callas, P., Velez, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14936587
Crothers, J. W., Chu, N. D., Nguyen, L. T. T., Phillips, M., Collins, C. C., Fortner, K. A., del Río, R., Lavoie, B., Callas, P., Velez, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14936584
Crothers, J. W., Chu, N. D., Nguyen, L. T. T., Phillips, M., Collins, C. C., Fortner, K. A., del Río, R., Lavoie, B., Callas, P., Velez, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14936578
Wilson, B. C., Vatanen, T., Jayasinghe, T. N., Leong, K. S. W., Derraik, J. G., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14594454
Shtossel, O., Turjeman, S., Riumin, A., Goldberg, M. R., Elizur, A., Bekor, Y., Mor, H., Koren, O., & Louzoun, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23949880
Li, M., Dai, L., Yang, Y., Chen, S., Ma, J., & Feng, P. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1700764
Metadata
- Authors
- Rossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., Zoetendal, E. G., D’Haens, G. R., & Ponsioen, C. Y.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Wageningen University & Research (NL)
- Corresponding author
- Ponsioen, Cyriel Y.
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 149
- Issue
- 1
- Pages
- 110-118.e4
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1994882377
- Cited by
- 921
- References
- 29
- Citations by year
- 2026: 30 · 2025: 45 · 2024: 64 · 2023: 69 · 2022: 86 · 2021: 93 · 2020: 128 · 2019: 113 · 2018: 84 · 2017: 87 · 2016: 83 · 2015: 36
- FWCI
- 66.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- fecal microbiota transplantation, ulcerative colitis, clinical remission, endoscopic remission, Clostridium cluster XIVa, Clostridium cluster IV, gut microbiota composition, adverse events
- MeSH terms
- Adult, Aged, Biological Therapy, Colitis, Ulcerative, Double-Blind Method, Feces, Female, Humans, Intubation, Gastrointestinal, Male, Middle Aged, Remission Induction, Treatment Outcome, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
